In NSCLC, expression of AFAP1-AS1 is significantly increased in tumor tissues, and knockdown of AFAP1-AS1 significantly inhibits the invasive and migration capability of lung cancer cells (Zeng et al., 2016). This evidence concerns the gene AFAP1 and non-small cell lung carcinoma.